Additional information
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
₹ 2800
EX1753 PROSTATE HEALTH INDEX (PHI) | |||||||
Specimen: | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. | ||||||
Stability: |
|
||||||
Method: | CMIA, CLIA | ||||||
Comment: | Samples received on holidays will be reported in the next schedule/next working day. | ||||||
Report: | Contact us to know the TAT. | ||||||
Usage: | Prostate health index (phi) combines three PSA forms (total PSA, free PSA, and p2PSA) into a single score. p2PSA test measures the [-2]proPSA concentration in serum, [-2]proPSA is one of the isoforms of free PSA and has been determined to be most specific to Prostate cancer. phi demonstrates a significant improvement in clinical specificity for prostate cancer detection, relative to PSA alone in men 50 years of age or older with a PSA range of 2-10 ng/mL and with non-suspicious digital rectal exam (DRE) findings. At 95% clinical sensitivity, the clinical specificity for phi is 18.2% as compared to 6.6% for percentage free PSA in the diagnostic grey zone. A low phi result indicates a lower risk of Prostate cancer, while an elevated phi result may suggest that a prostate biopsy is necessary to rule out cancer. | ||||||
Doctor Specialty: | Oncologist | ||||||
Disease: | Prostate Cancer | ||||||
Components: | *PSA, Total *PSA, Free *P2PSA | ||||||
Courier Charges: | |||||||
Home Collection: | Available (*T&C Apply) | ||||||
Department: | Biochemistry | ||||||
Pre Test Information: | Do not give samples within 7 days of Digital Rectal Examination (DRE) or Rectal Prostatic Ultrasonography. |
a division of exult cares pvt. ltd.
Reviews
There are no reviews yet.